Lymphedema Therapy (United States)
- Research works
- 33 ▼ 21% vs 2013–17
- Citations
- 759 23.2 per fractional work
- Top-10% rate
- 2.2% record average 16.5%
- Open access
- 41% world 28%
Not ranked overall: Lymphedema Therapy (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Which keywords describe research at Lymphedema Therapy (United States)?
By fractional works in all years, weighted toward what it does more of than the world: Inflammation, Lymphangiogenesis, VEGF-C, Quality of Life, Treatment, Clinical Practice Guidelines, Epidemiology and Chronic Venous Insufficiency.
- Ethical Climate
- Health-related Quality of Life
- Fibrosis
- Chylothorax
- Management
- Chronic Venous Insufficiency
- Treatment
- Quality of Life
- Lymphangiogenesis
- Inflammation
- VEGF-C
- Epidemiology
- Clinical Practice Guidelines
- Varicose Veins
- Pediatric
- Chylous Ascites
- Systemic Sclerosis
- Botulinum Toxin
- Moral Distress
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 19 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 19 words, with their numbers
- Inflammation11▲ 14×4 topics
- Lymphangiogenesis11▲ 2109×1 topic
- VEGF-C11▲ 2109×1 topic
- Quality of Life7▲ 17×10 topics
- Epidemiology6▲ 4.7×10 topics
- Treatment6▲ 15×9 topics
- Clinical Practice Guidelines6▲ 30×4 topics
- Chronic Venous Insufficiency5▲ 682×1 topic
- Varicose Veins5▲ 682×1 topic
- Management3▲ 11×5 topics
- Pediatric3▲ 110×3 topics
- Chylothorax2▲ 875×1 topic
- Chylous Ascites2▲ 875×1 topic
- Fibrosis2▲ 28×1 topic
- Systemic Sclerosis2▲ 168×1 topic
- Health-related Quality of Life2▲ 21×3 topics
- Botulinum Toxin1▲ 56×2 topics
- Ethical Climate1▲ 73×1 topic
- Moral Distress1▲ 73×1 topic
Which research topics does Lymphedema Therapy (United States) publish most on?
By volume in 2022–2025: Lymphatic System and Diseases, Diagnosis and Treatment of Venous Diseases, Systemic Sclerosis and Related Diseases and Lymphatic Disorders and Treatments.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Lymphatic System and Diseases Oncology 4 works
- 2 Diagnosis and Treatment of Venous Diseases Surgery 2 works
- 3 Systemic Sclerosis and Related Diseases Pathology and Forensic Medicine 1 works
- 4 Lymphatic Disorders and Treatments Surgery 1 works
- 5 Myofascial pain diagnosis and treatment Cell Biology 1 works
- 6 Sympathectomy and Hyperhidrosis Treatments Physiology 0 works
- 7 Cancer survivorship and care Oncology 0 works
- 8 Infectious Diseases and Tuberculosis Surgery 0 works
- 9 Mycobacterium research and diagnosis Epidemiology 0 works
- 10 Autoimmune and Inflammatory Disorders Research Hematology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Lymphedema Therapy (United States)'s research output changed?
Output in 2018–2022 was 21% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.